Selected research
Market Structure
Global Pharmaceutical Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pharmaceutical Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Drugs include Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Merck & Co. (MSD), AstraZeneca, AbbVie, AbbVie, Amgen and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pharmaceutical Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Drugs Segment by Company
Boehringer Ingelheim
Bristol-Myers Squibb
Gilead Sciences
Merck & Co. (MSD)
AstraZeneca
AbbVie
AbbVie
Amgen
Bayer
GlaxoSmithKline (GSK)
Pfizer
Eli Lilly
Roche
Novo Nordisk
Novartis
Johnson & Johnson
Sanofi
Teva
Takeda
Takeda
Pharmaceutical Drugs Segment by Type
Brand Drugs
Generic Drug
Pharmaceutical Drugs Segment by Application
Hospital
Clinic
Other
Pharmaceutical Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Drugs industry.
Chapter 3: Detailed analysis of Pharmaceutical Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brand Drugs
- Generic Drug
Applications
- Hospital
- Clinic
- Other
Companies covered
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Gilead Sciences
- Merck & Co. (MSD)
- AstraZeneca
- AbbVie
- AbbVie
- Amgen
- Bayer
- GlaxoSmithKline (GSK)
- Pfizer
- Eli Lilly
- Roche
- Novo Nordisk
- Novartis
- Johnson & Johnson
- Sanofi
- Teva
- Takeda
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmaceutical Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Brand Drugs
- 1.2.3 Generic Drug
- 1.3 Market Analysis by Application
- 1.3.1 Global Pharmaceutical Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Pharmaceutical Drugs Growth Trends by Region
- 1.5.1 Global Pharmaceutical Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pharmaceutical Drugs Market Size by Region (2021-2026)
- 1.5.3 Pharmaceutical Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pharmaceutical Drugs Market Dynamics
- 2.1 Pharmaceutical Drugs Industry Trends
- 2.2 Pharmaceutical Drugs Industry Drivers
- 2.3 Pharmaceutical Drugs Industry Opportunities and Challenges
- 2.4 Pharmaceutical Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pharmaceutical Drugs Revenue by Company (2021-2026)
- 3.2 Global Pharmaceutical Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pharmaceutical Drugs Key Company Head office and Area Served
- 3.4 Global Pharmaceutical Drugs Company, Product Type & Application
- 3.5 Global Pharmaceutical Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pharmaceutical Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pharmaceutical Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Pharmaceutical Drugs Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Drugs Market by Type
- 4.1 Global Pharmaceutical Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pharmaceutical Drugs Market Size by Type (2021-2032)
- 4.3 Global Pharmaceutical Drugs Market Size Share by Type (2021-2032)
5 Pharmaceutical Drugs Market by Application
- 5.1 Global Pharmaceutical Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Drugs Market Size by Application (2021-2032)
- 5.3 Global Pharmaceutical Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Boehringer Ingelheim Pharmaceutical Drugs Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 Bristol-Myers Squibb
- 6.2.1 Bristol-Myers Squibb Company Information
- 6.2.2 Bristol-Myers Squibb Business Overview
- 6.2.3 Bristol-Myers Squibb Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Bristol-Myers Squibb Pharmaceutical Drugs Product Portfolio
- 6.2.5 Bristol-Myers Squibb Recent Developments
- 6.3 Gilead Sciences
- 6.3.1 Gilead Sciences Company Information
- 6.3.2 Gilead Sciences Business Overview
- 6.3.3 Gilead Sciences Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Gilead Sciences Pharmaceutical Drugs Product Portfolio
- 6.3.5 Gilead Sciences Recent Developments
- 6.4 Merck & Co. (MSD)
- 6.4.1 Merck & Co. (MSD) Company Information
- 6.4.2 Merck & Co. (MSD) Business Overview
- 6.4.3 Merck & Co. (MSD) Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Merck & Co. (MSD) Pharmaceutical Drugs Product Portfolio
- 6.4.5 Merck & Co. (MSD) Recent Developments
- 6.5 AstraZeneca
- 6.5.1 AstraZeneca Company Information
- 6.5.2 AstraZeneca Business Overview
- 6.5.3 AstraZeneca Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 AstraZeneca Pharmaceutical Drugs Product Portfolio
- 6.5.5 AstraZeneca Recent Developments
- 6.6 AbbVie
- 6.6.1 AbbVie Company Information
- 6.6.2 AbbVie Business Overview
- 6.6.3 AbbVie Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AbbVie Pharmaceutical Drugs Product Portfolio
- 6.6.5 AbbVie Recent Developments
- 6.7 AbbVie
- 6.7.1 AbbVie Company Information
- 6.7.2 AbbVie Business Overview
- 6.7.3 AbbVie Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AbbVie Pharmaceutical Drugs Product Portfolio
- 6.7.5 AbbVie Recent Developments
- 6.8 Amgen
- 6.8.1 Amgen Company Information
- 6.8.2 Amgen Business Overview
- 6.8.3 Amgen Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Amgen Pharmaceutical Drugs Product Portfolio
- 6.8.5 Amgen Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Bayer Pharmaceutical Drugs Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 GlaxoSmithKline (GSK)
- 6.10.1 GlaxoSmithKline (GSK) Company Information
- 6.10.2 GlaxoSmithKline (GSK) Business Overview
- 6.10.3 GlaxoSmithKline (GSK) Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 GlaxoSmithKline (GSK) Pharmaceutical Drugs Product Portfolio
- 6.10.5 GlaxoSmithKline (GSK) Recent Developments
- 6.11 Pfizer
- 6.11.1 Pfizer Company Information
- 6.11.2 Pfizer Business Overview
- 6.11.3 Pfizer Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Pfizer Pharmaceutical Drugs Product Portfolio
- 6.11.5 Pfizer Recent Developments
- 6.12 Eli Lilly
- 6.12.1 Eli Lilly Company Information
- 6.12.2 Eli Lilly Business Overview
- 6.12.3 Eli Lilly Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Eli Lilly Pharmaceutical Drugs Product Portfolio
- 6.12.5 Eli Lilly Recent Developments
- 6.13 Roche
- 6.13.1 Roche Company Information
- 6.13.2 Roche Business Overview
- 6.13.3 Roche Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Roche Pharmaceutical Drugs Product Portfolio
- 6.13.5 Roche Recent Developments
- 6.14 Novo Nordisk
- 6.14.1 Novo Nordisk Company Information
- 6.14.2 Novo Nordisk Business Overview
- 6.14.3 Novo Nordisk Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Novo Nordisk Pharmaceutical Drugs Product Portfolio
- 6.14.5 Novo Nordisk Recent Developments
- 6.15 Novartis
- 6.15.1 Novartis Company Information
- 6.15.2 Novartis Business Overview
- 6.15.3 Novartis Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Novartis Pharmaceutical Drugs Product Portfolio
- 6.15.5 Novartis Recent Developments
- 6.16 Johnson & Johnson
- 6.16.1 Johnson & Johnson Company Information
- 6.16.2 Johnson & Johnson Business Overview
- 6.16.3 Johnson & Johnson Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Johnson & Johnson Pharmaceutical Drugs Product Portfolio
- 6.16.5 Johnson & Johnson Recent Developments
- 6.17 Sanofi
- 6.17.1 Sanofi Company Information
- 6.17.2 Sanofi Business Overview
- 6.17.3 Sanofi Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Sanofi Pharmaceutical Drugs Product Portfolio
- 6.17.5 Sanofi Recent Developments
- 6.18 Teva
- 6.18.1 Teva Company Information
- 6.18.2 Teva Business Overview
- 6.18.3 Teva Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Teva Pharmaceutical Drugs Product Portfolio
- 6.18.5 Teva Recent Developments
- 6.19 Takeda
- 6.19.1 Takeda Company Information
- 6.19.2 Takeda Business Overview
- 6.19.3 Takeda Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Takeda Pharmaceutical Drugs Product Portfolio
- 6.19.5 Takeda Recent Developments
- 6.20 Takeda
- 6.20.1 Takeda Company Information
- 6.20.2 Takeda Business Overview
- 6.20.3 Takeda Pharmaceutical Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Takeda Pharmaceutical Drugs Product Portfolio
- 6.20.5 Takeda Recent Developments
7 North America
- 7.1 North America Pharmaceutical Drugs Market Size (2021-2032)
- 7.2 North America Pharmaceutical Drugs Market Size by Type
- 7.2.1 North America Pharmaceutical Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Pharmaceutical Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Pharmaceutical Drugs Market Share by Type (2021-2032)
- 7.3 North America Pharmaceutical Drugs Market Size by Application
- 7.3.1 North America Pharmaceutical Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Pharmaceutical Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Pharmaceutical Drugs Market Share by Application (2021-2032)
- 7.4 North America Pharmaceutical Drugs Market Size by Country
- 7.4.1 North America Pharmaceutical Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pharmaceutical Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Pharmaceutical Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Pharmaceutical Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Drugs Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Drugs Market Size by Type
- 8.2.1 Europe Pharmaceutical Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Pharmaceutical Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Pharmaceutical Drugs Market Share by Type (2021-2032)
- 8.3 Europe Pharmaceutical Drugs Market Size by Application
- 8.3.1 Europe Pharmaceutical Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Pharmaceutical Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Pharmaceutical Drugs Market Share by Application (2021-2032)
- 8.4 Europe Pharmaceutical Drugs Market Size by Country
- 8.4.1 Europe Pharmaceutical Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pharmaceutical Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Pharmaceutical Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Pharmaceutical Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pharmaceutical Drugs Market Size (2021-2032)
- 9.2 China Pharmaceutical Drugs Market Size by Type
- 9.2.1 China Pharmaceutical Drugs Market Size by Type (2021-2026)
- 9.2.2 China Pharmaceutical Drugs Market Size by Type (2027-2032)
- 9.2.3 China Pharmaceutical Drugs Market Share by Type (2021-2032)
- 9.3 China Pharmaceutical Drugs Market Size by Application
- 9.3.1 China Pharmaceutical Drugs Market Size by Application (2021-2026)
- 9.3.2 China Pharmaceutical Drugs Market Size by Application (2027-2032)
- 9.3.3 China Pharmaceutical Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pharmaceutical Drugs Market Size (2021-2032)
- 10.2 Asia Pharmaceutical Drugs Market Size by Type
- 10.2.1 Asia Pharmaceutical Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Pharmaceutical Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Pharmaceutical Drugs Market Share by Type (2021-2032)
- 10.3 Asia Pharmaceutical Drugs Market Size by Application
- 10.3.1 Asia Pharmaceutical Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Pharmaceutical Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Pharmaceutical Drugs Market Share by Application (2021-2032)
- 10.4 Asia Pharmaceutical Drugs Market Size by Country
- 10.4.1 Asia Pharmaceutical Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pharmaceutical Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Pharmaceutical Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Pharmaceutical Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pharmaceutical Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pharmaceutical Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pharmaceutical Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pharmaceutical Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pharmaceutical Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst